Hi ,
I'm Ken, one of the co-founders of Super Speciosa. I'm writing with exciting news: our kratom was used in the first-ever clinical trial of kratom consumption safety by the FDA.
This is a groundbreaking study. While the FDA has warned consumers about kratom, increasing stigma around this plant, it had never before conducted a study to understand its clinical impact.
We hope this study was the first step towards the FDA changing their perspective on kratom – to show that kratom is indeed safe, and to promote further research on its possibilities. It is real, tangible progress in our field.
The goal of this study was to evaluate if kratom is safe to consume, and results from the study are compelling. Even though the clinical trial tested kratom at higher doses than we'd ever recommend, not a single serious adverse event was reported. The study was a strong start in proving that kratom is safe.
One of the reasons kratom is poorly studied is because finding reliable, consistent, high quality sources of kratom is difficult across the industry. The fact that our kratom was chosen by the top scientists to study in a clinical setting speaks to our commitment to rigorous testing and transparency in our top-quality kratom — a standard we've always held ourselves to as your trusted brand.
While past media portrayals were mostly negative, we're also thrilled to see major publishers like Bloomberg take interest in reporting on the FDA's first research into kratom safety for human consumption. This is a huge milestone for the kratom community as we are now seeing positive research taking place and being published in major media channels.
My hope in participating in studies like this is to continue the national conversation about kratom, and to help elevate safety and quality standards across the industry. This study is significant, as it has finally reached the top regulatory institution in our country, and we believe this is the start of something much bigger.
Read more about the study here.
If you have any questions or thoughts, please feel free to let us know — I always want to hear from you.
Thanks,
Ken Loricchio
| You received this email from Super Organics. If you would like to unsubscribe, click here. |
0 komentar:
Posting Komentar